Dexamethasone implant in vitreoretinal surgery for diabetic retinal detachment: A retrospective comparative study
Indian Journal of Ophthalmology · 2026
DOI: 10.4103/ijo.ijo_892_26 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Indian Journal of Ophthalmology, 2026. Verfasst von Vikas Ambiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Armed Forces Medical College, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Dexamethasone, Retinal Detachment, Visual Acuity, Diabetic Retinopathy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the effect of simultaneous intraoperative dexamethasone implant on visual and anatomical outcomes in eyes undergoing pars plana vitrectomy (PPV) with silicone oil for diabetic retinal detachment (DRD).
Design
Retrospective comparative case series.
Methods
Setting: Tertiary eye care center. Study Population: Sixty eyes of 60 patients with DRD. Intervention/Observation Procedure(s): Medical records of 60 eyes of 60 patients undergoing PPV with silicone oil for diabetic tractional retinal detachment or combined tractional-rhegmatogenous retinal detachment were retrospectively reviewed. Thirty eyes underwent standard PPV with silicone oil tamponade, while 30 eyes underwent PPV with simultaneous intraoperative dexamethasone implant. Silicone oil removal was performed at 2–3 months. All patients were followed for at least 6 months. Main Outcome Measure(s): The main outcome measures were best-corrected visual acuity (BCVA) and central macular thickness (CMT). Secondary outcomes included postoperative macular edema (ME), epiretinal membrane (ERM) formation, need for rescue dexamethasone therapy, anatomical success, and requirement for secondary internal limiting membrane peeling.
Results
At 6 months, BCVA was 0.62 ± 0.14 logMAR in Group A versus 0.48 ± 0.12 logMAR in Group B ( P < 0.01). Mean CMT was 314 ± 35 μm versus 272 ± 28 μm, respectively ( P < 0.05). ME occurred in 30% of eyes in Group A versus 10% in Group B. Rescue dexamethasone was required in 16.7% of Group A and none in Group B. ERM formation was observed in 23.3% versus 6.7% ( P = 0.07), and secondary ILM peeling was required in 10% versus 0% in Groups A and B, respectively. Retinal reattachment rates at 6 months were comparable (93.3% vs 96.7%).
Conclusion
Intraoperative dexamethasone implantation may improve postoperative visual and anatomical outcomes and warrant further evaluation in prospective randomized studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Armed Forces Medical College, Pune, Maharashtra, India.
Zitieren
APA
Ambiya, V., Modi, S., Kapoor, G., Sharma, V. K., Bhatta, S., & Rahul (2026). Dexamethasone implant in vitreoretinal surgery for diabetic retinal detachment: A retrospective comparative study. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_892_26
Vancouver
Ambiya V, Modi S, Kapoor G, Sharma VK, Bhatta S, Rahul. Dexamethasone implant in vitreoretinal surgery for diabetic retinal detachment: A retrospective comparative study. Indian Journal of Ophthalmology. 2026. doi:10.4103/ijo.ijo_892_26
BibTeX
@article{Ambiya2026,
author = {Ambiya, Vikas and Modi, Swati and Kapoor, Gaurav and Sharma, Vijay K and Bhatta, Sunandan and Rahul},
title = {Dexamethasone implant in vitreoretinal surgery for diabetic retinal detachment: A retrospective comparative study},
journal = {Indian Journal of Ophthalmology},
year = {2026},
doi = {10.4103/ijo.ijo_892_26}
}
EUVIMED